Ketamine, not fentanyl, suppresses pain-related magnetic fields associated with trigeminally innervated area following CO2 laser stimulation

Nobuyuki Matsuura, Yoshiyuki Shibukawa, Motoichiro Kato, Tatsuya Ichinohe, Takashi Suzuki, Yuzuru Kaneko

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

A variety of pharmacological agents are clinically used to treat pain-related diseases, including in the orofacial region. The effects of analgesics upon cerebral sites responsible for pain perception have yet to be determined. The aim of the present study was to examine the effects of ketamine, an N-methyl-d-aspartate (NMDA) antagonist, and fentanyl, a narcotic analgetic, on pain-related somatosensory-evoked magnetic fields (pain-SEFs) induced by CO2 laser stimulation of the trigeminally innervated area. Two peaks with latencies of approximately 120 and 200 ms were observed in pain-SEFs after CO2 laser stimulation. Peaks with approximately 120 ms latency were detected in the bilateral secondary somatosensory cortices. Amplitude of pain-SEFs after CO2 laser stimulation increased in an intensity-dependent manner. Ketamine suppressed amplitude and prolonged latency of pain-SEFs, whilst fentanyl did not. This suggests that ketamine inhibits NMDA receptor-mediated neurotransmission in a pain input pathway to the cerebral cortex, thereby exerting an analgesic effect. Fentanyl, which acts via opioid receptors, is believed to act differently to ketamine in the pain input process.

Original languageEnglish
Pages (from-to)105-111
Number of pages7
JournalNeuroscience Research
Volume62
Issue number2
DOIs
Publication statusPublished - 2008 Oct

Fingerprint

Gas Lasers
Ketamine
Fentanyl
Magnetic Fields
Pain
Analgesics
Pain Perception
Somatosensory Cortex
Narcotics
Opioid Receptors
Aspartic Acid
Synaptic Transmission
Cerebral Cortex
Pharmacology

Keywords

  • CO laser
  • Fentanyl
  • Ketamine
  • Magnetoencephalography
  • Secondary somatosensory area
  • Somatosensory-evoked magnetic field

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Ketamine, not fentanyl, suppresses pain-related magnetic fields associated with trigeminally innervated area following CO2 laser stimulation. / Matsuura, Nobuyuki; Shibukawa, Yoshiyuki; Kato, Motoichiro; Ichinohe, Tatsuya; Suzuki, Takashi; Kaneko, Yuzuru.

In: Neuroscience Research, Vol. 62, No. 2, 10.2008, p. 105-111.

Research output: Contribution to journalArticle

Matsuura, Nobuyuki ; Shibukawa, Yoshiyuki ; Kato, Motoichiro ; Ichinohe, Tatsuya ; Suzuki, Takashi ; Kaneko, Yuzuru. / Ketamine, not fentanyl, suppresses pain-related magnetic fields associated with trigeminally innervated area following CO2 laser stimulation. In: Neuroscience Research. 2008 ; Vol. 62, No. 2. pp. 105-111.
@article{85e994629c8e4c939b6815b879eb8d73,
title = "Ketamine, not fentanyl, suppresses pain-related magnetic fields associated with trigeminally innervated area following CO2 laser stimulation",
abstract = "A variety of pharmacological agents are clinically used to treat pain-related diseases, including in the orofacial region. The effects of analgesics upon cerebral sites responsible for pain perception have yet to be determined. The aim of the present study was to examine the effects of ketamine, an N-methyl-d-aspartate (NMDA) antagonist, and fentanyl, a narcotic analgetic, on pain-related somatosensory-evoked magnetic fields (pain-SEFs) induced by CO2 laser stimulation of the trigeminally innervated area. Two peaks with latencies of approximately 120 and 200 ms were observed in pain-SEFs after CO2 laser stimulation. Peaks with approximately 120 ms latency were detected in the bilateral secondary somatosensory cortices. Amplitude of pain-SEFs after CO2 laser stimulation increased in an intensity-dependent manner. Ketamine suppressed amplitude and prolonged latency of pain-SEFs, whilst fentanyl did not. This suggests that ketamine inhibits NMDA receptor-mediated neurotransmission in a pain input pathway to the cerebral cortex, thereby exerting an analgesic effect. Fentanyl, which acts via opioid receptors, is believed to act differently to ketamine in the pain input process.",
keywords = "CO laser, Fentanyl, Ketamine, Magnetoencephalography, Secondary somatosensory area, Somatosensory-evoked magnetic field",
author = "Nobuyuki Matsuura and Yoshiyuki Shibukawa and Motoichiro Kato and Tatsuya Ichinohe and Takashi Suzuki and Yuzuru Kaneko",
year = "2008",
month = "10",
doi = "10.1016/j.neures.2008.06.006",
language = "English",
volume = "62",
pages = "105--111",
journal = "Neuroscience Research",
issn = "0168-0102",
publisher = "Elsevier Ireland Ltd",
number = "2",

}

TY - JOUR

T1 - Ketamine, not fentanyl, suppresses pain-related magnetic fields associated with trigeminally innervated area following CO2 laser stimulation

AU - Matsuura, Nobuyuki

AU - Shibukawa, Yoshiyuki

AU - Kato, Motoichiro

AU - Ichinohe, Tatsuya

AU - Suzuki, Takashi

AU - Kaneko, Yuzuru

PY - 2008/10

Y1 - 2008/10

N2 - A variety of pharmacological agents are clinically used to treat pain-related diseases, including in the orofacial region. The effects of analgesics upon cerebral sites responsible for pain perception have yet to be determined. The aim of the present study was to examine the effects of ketamine, an N-methyl-d-aspartate (NMDA) antagonist, and fentanyl, a narcotic analgetic, on pain-related somatosensory-evoked magnetic fields (pain-SEFs) induced by CO2 laser stimulation of the trigeminally innervated area. Two peaks with latencies of approximately 120 and 200 ms were observed in pain-SEFs after CO2 laser stimulation. Peaks with approximately 120 ms latency were detected in the bilateral secondary somatosensory cortices. Amplitude of pain-SEFs after CO2 laser stimulation increased in an intensity-dependent manner. Ketamine suppressed amplitude and prolonged latency of pain-SEFs, whilst fentanyl did not. This suggests that ketamine inhibits NMDA receptor-mediated neurotransmission in a pain input pathway to the cerebral cortex, thereby exerting an analgesic effect. Fentanyl, which acts via opioid receptors, is believed to act differently to ketamine in the pain input process.

AB - A variety of pharmacological agents are clinically used to treat pain-related diseases, including in the orofacial region. The effects of analgesics upon cerebral sites responsible for pain perception have yet to be determined. The aim of the present study was to examine the effects of ketamine, an N-methyl-d-aspartate (NMDA) antagonist, and fentanyl, a narcotic analgetic, on pain-related somatosensory-evoked magnetic fields (pain-SEFs) induced by CO2 laser stimulation of the trigeminally innervated area. Two peaks with latencies of approximately 120 and 200 ms were observed in pain-SEFs after CO2 laser stimulation. Peaks with approximately 120 ms latency were detected in the bilateral secondary somatosensory cortices. Amplitude of pain-SEFs after CO2 laser stimulation increased in an intensity-dependent manner. Ketamine suppressed amplitude and prolonged latency of pain-SEFs, whilst fentanyl did not. This suggests that ketamine inhibits NMDA receptor-mediated neurotransmission in a pain input pathway to the cerebral cortex, thereby exerting an analgesic effect. Fentanyl, which acts via opioid receptors, is believed to act differently to ketamine in the pain input process.

KW - CO laser

KW - Fentanyl

KW - Ketamine

KW - Magnetoencephalography

KW - Secondary somatosensory area

KW - Somatosensory-evoked magnetic field

UR - http://www.scopus.com/inward/record.url?scp=50449099125&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=50449099125&partnerID=8YFLogxK

U2 - 10.1016/j.neures.2008.06.006

DO - 10.1016/j.neures.2008.06.006

M3 - Article

C2 - 18655812

AN - SCOPUS:50449099125

VL - 62

SP - 105

EP - 111

JO - Neuroscience Research

JF - Neuroscience Research

SN - 0168-0102

IS - 2

ER -